CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CVS - US1266501006 - Common Stock
65.4 EUR
-4.6 (-6.57%)
1CVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of 1CVS have multiple concerns. 1CVS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1CVS was profitable.
1CVS had a positive operating cash flow in the past year.
1CVS had positive earnings in each of the past 5 years.
In the past 5 years 1CVS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1CVS (0.18%) is worse than 67.74% of its industry peers.
1CVS has a worse Return On Equity (0.64%) than 70.97% of its industry peers.
1CVS has a Return On Invested Capital (4.90%) which is in line with its industry peers.
1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 6.56%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROIC | 4.9% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
Looking at the Profit Margin, with a value of 0.12%, 1CVS is doing worse than 67.74% of the companies in the same industry.
In the last couple of years the Profit Margin of 1CVS has declined.
Looking at the Operating Margin, with a value of 2.73%, 1CVS is doing worse than 67.74% of the companies in the same industry.
In the last couple of years the Operating Margin of 1CVS has declined.
With a Gross Margin value of 13.88%, 1CVS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1CVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
2. Health
2.1 Basic Checks
1CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1CVS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1CVS has less shares outstanding
1CVS has a worse debt/assets ratio than last year.
2.2 Solvency
1CVS has an Altman-Z score of 2.25. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
1CVS has a Altman-Z score (2.25) which is in line with its industry peers.
The Debt to FCF ratio of 1CVS is 10.46, which is on the high side as it means it would take 1CVS, 10.46 years of fcf income to pay off all of its debts.
1CVS's Debt to FCF ratio of 10.46 is in line compared to the rest of the industry. 1CVS outperforms 48.39% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that 1CVS is somewhat dependend on debt financing.
1CVS's Debt to Equity ratio of 0.85 is in line compared to the rest of the industry. 1CVS outperforms 51.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.62
WACC7.92%
2.3 Liquidity
A Current Ratio of 0.83 indicates that 1CVS may have some problems paying its short term obligations.
1CVS has a Current ratio of 0.83. This is comparable to the rest of the industry: 1CVS outperforms 41.94% of its industry peers.
1CVS has a Quick Ratio of 0.83. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.63, 1CVS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.87% over the past year.
The Earnings Per Share has been decreasing by -5.20% on average over the past years.
1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.82%.
The Revenue has been growing slightly by 7.74% on average over the past years.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
3.2 Future
1CVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.34% yearly.
Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.18 indicates a reasonable valuation of 1CVS.
Based on the Price/Earnings ratio, 1CVS is valued cheaper than 83.87% of the companies in the same industry.
1CVS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.59.
Based on the Price/Forward Earnings ratio of 10.61, the valuation of 1CVS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 80.65% of the companies listed in the same industry.
1CVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.03.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 10.61 |
4.2 Price Multiples
1CVS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.45 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1CVS's earnings are expected to grow with 14.66% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y15.41%
EPS Next 3Y14.66%
5. Dividend
5.1 Amount
1CVS has a Yearly Dividend Yield of 3.42%.
Compared to an average industry Dividend Yield of 1.57, 1CVS pays a better dividend. On top of this 1CVS pays more dividend than 90.32% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, 1CVS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
5.2 History
The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
722.81% of the earnings are spent on dividend by 1CVS. This is not a sustainable payout ratio.
1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
BIT:1CVS (12/8/2025, 7:00:00 PM)
65.4
-4.6 (-6.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.68%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap83.02B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80.61
Price Target77.36 (18.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
Yearly Dividend2.26
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)11.07%
PT rev (3m)10.58%
EPS NQ rev (1m)4.24%
EPS NQ rev (3m)5.66%
EPS NY rev (1m)3.6%
EPS NY rev (3m)3.85%
Revenue NQ rev (1m)2.19%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)1.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 10.61 | ||
| P/S | 0.25 | ||
| P/FCF | 15.45 | ||
| P/OCF | 10.67 | ||
| P/B | 1.33 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.85
EY8.94%
EPS(NY)6.16
Fwd EY9.42%
FCF(TTM)4.23
FCFY6.47%
OCF(TTM)6.13
OCFY9.37%
SpS265.06
BVpS49.05
TBVpS-25.92
PEG (NY)0.49
PEG (5Y)N/A
Graham Number80.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROCE | 6.61% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.26% | ||
| ROICexgc | 19.51% | ||
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% | ||
| FCFM | 1.6% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.71% | ||
| Interest Coverage | -3.53 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 1341.79% | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.25 |
F-Score6
WACC7.92%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.12%
EBIT Next 3Y19.3%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%
CVS HEALTH CORP / 1CVS.MI FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1CVS.MI.
Can you provide the valuation status for CVS HEALTH CORP?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
What is the profitability of 1CVS stock?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for 1CVS stock?
The Price/Earnings (PE) ratio for CVS HEALTH CORP (1CVS.MI) is 11.18 and the Price/Book (PB) ratio is 1.33.
Can you provide the expected EPS growth for 1CVS stock?
The Earnings per Share (EPS) of CVS HEALTH CORP (1CVS.MI) is expected to grow by 22.97% in the next year.